
Targeting Inflammation in Type 1 Diabetes
Summary A recent study reveals a potential new treatment strategy for Type 1 diabetes by targeting the inflammation-driving protein TYK2. This dual-action approach protects insulin-producing beta cells while reducing the immune system’s attack on them. […]